Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_assertion type Assertion NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_head.
- NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_assertion description "[Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_provenance.
- NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_assertion evidence source_evidence_literature NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_provenance.
- NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_assertion SIO_000772 12738752 NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_provenance.
- NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_assertion wasDerivedFrom befree-2016 NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_provenance.
- NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_assertion wasGeneratedBy ECO_0000203 NP393724.RA_Yy_rOH8CdZtTjafslBeXtjwdZHUmsaB4_J4VY_rPOM130_provenance.